| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/21/2011 | US20110091377 Biomarkers for melanoma |
| 04/21/2011 | US20110091363 Vial presence indicator for vial-bearing rack |
| 04/21/2011 | US20110091357 Analytical systems, devices, and cartridges therefor |
| 04/21/2011 | US20110091356 Micro-fluidic device and sample testing method using the same |
| 04/21/2011 | US20110089786 Arrangement of a piezoacoustic resonator on an acoustic mirror of a substrate, method for producing the arrangement and use of the arrangement |
| 04/21/2011 | US20110089037 Biological particles |
| 04/21/2011 | US20110088454 Device for selectively determining the quantity of oil mist or aerosols |
| 04/21/2011 | US20110088451 Nonvisual indication of an unwanted chemical in an ingestible substance |
| 04/21/2011 | US20110088446 Pre-calibrated replaceable sensor module for a breath alcohol testing device |
| 04/21/2011 | DE102010042043A1 Utilization of substrate for non-invasive determination of epidermal barrier of skin of human, using reaction adhesive, where substrate with adhesive and removed skin layers is utilized as sample for determination of barriers |
| 04/21/2011 | DE102010010112A1 Vorrichtung zur selektiven Bestimmung der Menge von Ölnebel oder Aerosolen Means for selectively determining the amount of oil mist or aerosols |
| 04/21/2011 | DE102009048811A1 Biosensorvorrichtung mit Selbsttesteinrichtung Biosensor with self-test device |
| 04/21/2011 | DE102009048790A1 Biosensorvorrichtung mit Filterüberwachungseinrichtung Biosensor with filter monitoring device |
| 04/21/2011 | DE102009043236A1 Multifunktions-Steuerventil für Gasmessgeräte Multi-function control valve for gas detectors |
| 04/21/2011 | CA2803833A1 All-protein implantable, resorbable reflectors |
| 04/21/2011 | CA2780464A1 Acute kidney injury risk testing |
| 04/21/2011 | CA2777920A1 Aptamer capable of binding to viral hemorrhagic septicemia virus |
| 04/21/2011 | CA2777807A1 An assay method and devices involving the use of magnetic particles |
| 04/21/2011 | CA2777800A1 Biomarkers and methods for measuring and monitoring inflammatory disease activity |
| 04/21/2011 | CA2777752A1 Mutant low-density lipoprotein receptor related protein with increased binding to alzheimer amyloid-beta peptide |
| 04/21/2011 | CA2777699A1 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 04/21/2011 | CA2777690A1 Mass spectrometry quantitation of p450 protein isoforms in hepatocytes |
| 04/21/2011 | CA2777565A1 Hematopoietic growth factor mimetic small molecule compounds and their uses |
| 04/21/2011 | CA2777501A1 Biomarkers and identification methods for the early detection and recurrence prediction of breast cancer using nmr |
| 04/21/2011 | CA2777499A1 Methods for identifying animals with a reduced ability to digest lipid and protein |
| 04/21/2011 | CA2777297A1 Methods and apparatus for downhole characterization of emulsion stability |
| 04/21/2011 | CA2777235A1 Biomarker for identification of melanoma tumor cells |
| 04/21/2011 | CA2777226A1 Cancer treatment |
| 04/21/2011 | CA2777013A1 Marker associated with non-alcoholic steatohepatitis |
| 04/21/2011 | CA2775613A1 Protein detection via nanoreporters |
| 04/21/2011 | CA2775402A1 Il-1 binding proteins |
| 04/21/2011 | CA2774422A1 Multi-modality contrast and brightfield context rendering for enhanced pathology determination and multi-analyte detection in tissue |
| 04/21/2011 | CA2773527A1 Novel biomarkers of disease histopathology |
| 04/21/2011 | CA2772789A1 Bare single-layer graphene membrane having a nanopore enabling high-sensitivity molecular detection and analysis |
| 04/21/2011 | CA2718205A1 Kit and method for the labelling of biomolecules |
| 04/20/2011 | EP2312320A1 Method for determining the stage of ulcerative colitis or interstitial pneumonitis and reagent kit thereof |
| 04/20/2011 | EP2312319A1 Process of screening a molecule as a candidate drug for the treatment of bipolar disorder |
| 04/20/2011 | EP2312318A1 Prion protein ligands and methods of use |
| 04/20/2011 | EP2312317A2 Fluorescent detection system and dye set for use therewith |
| 04/20/2011 | EP2312316A1 Anti-EPHA2 antibodies as a cancer diagnostic |
| 04/20/2011 | EP2312315A1 Methods for diagnosis and treatment of diseases having an autoimmune and/or inflammatory component |
| 04/20/2011 | EP2312314A2 Fecal sampling device and method |
| 04/20/2011 | EP2312313A2 Immobilized probes and methods of detecting conformationally altered prion proteins |
| 04/20/2011 | EP2312312A2 Detection of conformationally altered proteins and prions |
| 04/20/2011 | EP2312311A1 Determination of white blood cell differential and reticulocyte counts |
| 04/20/2011 | EP2312310A1 Device and method for analyzing a rock mineral sample |
| 04/20/2011 | EP2312308A1 Apparatus and method for analysis by capillary electrophoretic method |
| 04/20/2011 | EP2312305A1 Electrochemical sensor |
| 04/20/2011 | EP2312304A1 Detection of analytes using reorganization energy |
| 04/20/2011 | EP2311992A1 Method for rapid detection and identification of bioagents |
| 04/20/2011 | EP2311980A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 04/20/2011 | EP2311979A1 Compositions, kits and methods for identification, assessment, prevention and therapy of cervical cancer |
| 04/20/2011 | EP2311978A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 04/20/2011 | EP2311975A1 Electrophoretic biomolecules separation device |
| 04/20/2011 | EP2311960A2 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 04/20/2011 | EP2311957A1 Antigens from granulocytic Ehrlichia |
| 04/20/2011 | EP2311955A2 Osteoprotegerin binding proteins and their receptors |
| 04/20/2011 | EP2311954A1 Mutations in the Parkin gene, compositions, methods and uses |
| 04/20/2011 | EP2311953A1 Bone/joint disease susceptibility gene and use thereof |
| 04/20/2011 | EP2311952A2 Antibodies to MRT-1 protein or fragments thereof |
| 04/20/2011 | EP2311946A1 Anti-system asc amino acid transporter 2 (asct2) antibody |
| 04/20/2011 | EP2311944A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 04/20/2011 | EP2311939A1 Polypeptide immobilization |
| 04/20/2011 | EP2311934A2 Rapid detection of replicating cells |
| 04/20/2011 | EP2311895A1 Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups |
| 04/20/2011 | EP2311882A1 Reducing the immunogenicity of fusion proteins |
| 04/20/2011 | EP2311870A1 Compositions and methods for the treatment of immune related diseases |
| 04/20/2011 | EP2311868A1 Compositions and methods for the treatment of immune related diseases |
| 04/20/2011 | EP2311867A1 Trimeric binding proteins for trimeric cytokines |
| 04/20/2011 | EP2311865A1 Placental Growth Factor in Cancer Disease |
| 04/20/2011 | EP2311863A1 Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer |
| 04/20/2011 | EP2311862A2 Differential in tumour gene products and use of same |
| 04/20/2011 | EP2311861A2 Differential in tumour gene products and use of same |
| 04/20/2011 | EP2311860A2 Differential in tumour gene products and use of same |
| 04/20/2011 | EP2311852A1 Anti-infarction molecules |
| 04/20/2011 | EP2311530A2 Mammalian genes involved in infection |
| 04/20/2011 | EP2311499A1 Telomelysin-GFP gene-containing recombinant virus |
| 04/20/2011 | EP2311483A1 GCSF for use in treating a neurological disease with pathophysiological mechanisms involving ischemia or hypoxia |
| 04/20/2011 | EP2311468A1 Gene overexpressed in cancer |
| 04/20/2011 | EP2311445A1 Methods of preventing, treating and diagnosing disorders of protein aggregation |
| 04/20/2011 | EP2310864A1 Method for the preoperative determination of the intraoperative risk of bleeding of a patient |
| 04/20/2011 | EP2310863A1 Disintegration of cellular components in body fluids |
| 04/20/2011 | EP2310862A2 Optimizing selection of srm transitions for analysis of biomolecules by tandem mass spectrometry |
| 04/20/2011 | EP2310861A1 Healthy kidney biomarkers |
| 04/20/2011 | EP2310860A1 Blood glutathione as a biomarker for screening asymptomatic patients at risk for heart failure |
| 04/20/2011 | EP2310859A1 Identifying and quantifying biomarkers associated with preeclampsia |
| 04/20/2011 | EP2310858A1 New therapeutic and diagnostic methods for alzheimer's disease |
| 04/20/2011 | EP2310857A2 Electrophoretically enhanced detection of analytes on a solid support |
| 04/20/2011 | EP2310856A1 Method of monitoring microbiological deposits |
| 04/20/2011 | EP2310855A1 Multi-ligand capture agents and related compositions, methods and systems |
| 04/20/2011 | EP2310854A1 Detection of interactions between lipid complexes and lipid binding agents |
| 04/20/2011 | EP2310853A1 Assay |
| 04/20/2011 | EP2310852A1 O-glycans as diagnostic markers for inflammatory bowel disease |
| 04/20/2011 | EP2310851A2 Method and apparatus for determining the yield of at least one component |
| 04/20/2011 | EP2310850A1 A diagnostic method |
| 04/20/2011 | EP2310849A1 Method and apparatus for lighted test strip |
| 04/20/2011 | EP2310848A2 Characterization of biological samples |
| 04/20/2011 | EP2310843A1 Systems and methods including amperometric and voltammetric duty cycles |
| 04/20/2011 | EP2310833A2 Method for classifying and counting bacteria in body fluids |
| 04/20/2011 | EP2310827A2 Triaxial cell for the testing of geomaterials in compression and in shear |